AstraZeneca cops to rare, deadly side effect of COVID jab as lawsuits mount
New York PostApr 29
AstraZeneca Admits Existence of COVID Jab's Rare Side Effect
Image copyright: Ulet Ifansasti/Stringer/Getty Images News via Getty Images
The Facts
Pharmaceutical company AstraZeneca has admitted, in court documents filed as part of a class-action suit against it, that its COVID vaccine can produce a rare adverse effect.
In response to the suit accusing its jab of causing dozens of deaths and injuries, AstraZeneca — in documents presented to the UK High Court — said the jab can "in very rare cases" cause Thrombosis with Thrombocytopenia Syndrome, which causes blood clots and low platelet counts.
The Spin
Narrative A
AstraZeneca has always acknowledged this could be a very rare side effect of the jab. However, there could be other contributing factors to patients developing Thrombocytopenia Syndrome. Aside from the few instances where recipients may have suffered this side effect, the vaccine has saved millions wherever it was distributed.
Narrative B
As the claimants in this case can attest, AstraZeneca downplayed the risk of this vaccine while exaggerating its effectiveness. Otherwise healthy people have faced the consequences of these side effects and the pharmaceutical firm must compensate the ones who survived their unnecessary medical crises.
Nerd narrative
There's a 90% chance that before Jan. 1, 2032, an intranasal SARS-CoV-2 vaccine candidate will be approved by the USA, UK, EU, or Canada, according to the Metaculus prediction community.